
RIVASTIGMINE HYDROGEN TARTRATE
Human API for therapeutic applications. It is recommended for capsule and transdermal dosage form in the treatment of central nervous system diseases.Benefits:Meets USDMF, EDMF, CEP and KDMF
Reliable excipients and APIs meeting stringent pharmaceutical standards. Supporting safe, effective and compliant drug formulations.
Sort by



Let’s build your next solution together